Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes

Stock Information for Niagen Bioscience Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Niagen Bioscience Inc.

Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for ?-Klotho Anti-Aging Therapy
Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho
Avant Technologies, Inc. Issues Retraction of September 24, 2025 Press Release
Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks
From Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits
Doctors Are Being Outpaced by AI-Powered Algorithms -- Here's What It Means for Investors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.